![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
01 2care4 (1)
02 2care4 ApS (1)
03 Actavis Inc (2)
04 Cross Pharma AB (2)
05 Daiichi Sankyo (6)
06 Elite Laboratories, Inc. (2)
07 GSK (4)
08 IVAX Pharmaceuticals Inc (1)
09 Italfarmaco S.p.A (1)
10 Medartuum AB (2)
11 Novartis South Africa (Pty) Ltd (2)
12 ORIFARM GROUP AS (6)
13 Paranova Group AS (3)
14 Pharmachim AB (1)
15 Qdoxx Pharma (1)
16 Viatris (2)
01 CAP (1)
02 CAPSULE;ORAL (6)
03 Capsule (4)
04 Isradipina 5Mg 14 Joined' Oral Use (3)
05 PROLONGED-RELEASE CAPSULE, HARD (16)
06 Pit Capsule (1)
07 TAB (1)
08 TABLET (1)
09 TABLET, EXTENDED RELEASE;ORAL (4)
01 DISCN (6)
02 Originator (2)
03 RX (4)
04 Blank (25)
01 Clivoten (1)
02 DYNACIRC (2)
03 DYNACIRC CR (2)
04 Dynacirc (1)
05 Dynacirc Sro (1)
06 Eadin (1)
07 ISRADIPINE (6)
08 Lomir (1)
09 Lomir Or (1)
10 Lomir SRO (17)
11 Blank (4)
01 Italy (3)
02 Norway (1)
03 South Africa (2)
04 Sweden (17)
05 Switzerland (4)
06 USA (10)